Your browser doesn't support javascript.
loading
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
Sørrig, Rasmus; Klausen, Tobias W; Salomo, Morten; Vangsted, Annette J; Østergaard, Brian; Gregersen, Henrik; Frølund, Ulf Christian; Andersen, Niels F; Helleberg, Carsten; Andersen, Kristian T; Pedersen, Robert S; Pedersen, Per; Abildgaard, Niels; Gimsing, Peter.
Afiliação
  • Sørrig R; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Klausen TW; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Salomo M; Hematological Research Laboratory, Herlev Hospital, Herlev, Denmark.
  • Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Østergaard B; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Gregersen H; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Frølund UC; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
  • Andersen NF; Department of Hematology, Roskilde Hospital, Roskilde, Denmark.
  • Helleberg C; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Andersen KT; Department of Hematology, Herlev Hospital, Herlev, Denmark.
  • Pedersen RS; Department of Internal Medicine, Hematological Section, Vejle Hospital, Vejle, Denmark.
  • Pedersen P; Department of Internal Medicine, Hematological section, Holstebro Hospital, Holstebro, Denmark.
  • Abildgaard N; Department of Hematology, Esbjerg Hospital, Esbjerg, Denmark.
  • Gimsing P; Department of Hematology, Odense University Hospital, Odense, Denmark.
Eur J Haematol ; 97(3): 303-9, 2016 Sep.
Article em En | MEDLINE | ID: mdl-26710662
ABSTRACT
Several risk scores for disease progression in patients with smoldering multiple myeloma (SMM) have been proposed; however, all have been developed using single-center registries. To examine risk factors for time to progression (TTP) to multiple myeloma (MM) for SMM, we analyzed a nationwide population-based cohort of 321 patients with newly diagnosed SMM registered within the Danish Multiple Myeloma Registry between 2005 and 2014. Significant univariable risk factors for TTP were selected for multivariable Cox regression analyses. We found that both an M-protein ≥30 g/L and immunoparesis significantly influenced TTP (HR 2.7, 95%CI (1.5;4.7), P = 0.001, and HR 3.3, 95%CI (1.4;7.8), P = 0.002, respectively). High free light chain (FLC) ratio did not significantly influence TTP in our cohort. Therefore, our data do not support recent IMWG proposal of identifying patients with FLC ratio above 100 as having ultra high-risk of transformation to MM. Using only immunoparesis and M-protein ≥30 g/L, we created a scoring system to identify low-, intermediate-, and high-risk SMM. This first population-based study of patients with SMM confirms that an M-protein ≥30 g/L and immunoparesis remain important risk factors for progression to MM.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Vigilância da População / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Vigilância da População / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article